Deciphering Radiotherapy Resistance: A Proteomic Perspective

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Radiotherapy resistance is a major challenge in cancer treatment.
• Understanding the molecular mechanisms of radioresistance is crucial for effective therapy.
• Proteomics offers a powerful tool for studying tumor heterogeneity and treatment response.

Purpose of the Study:

• To review recent advances in proteomic technologies for identifying biomarkers of radiosensitivity and radioresistance.
• To highlight the application of proteomics in various cancer types, including head and neck, breast, lung, and prostate cancers.
• To discuss the potential of proteomics in overcoming radiation resistance and guiding precision oncology.

Main Methods:

• Mass spectrometry-based proteomics for high-throughput, quantitative analyses.
• Bioinformatic integration for biomarker and pathway identification.
• Review of current literature on proteomics applications in radiobiology.

Main Results:

• Proteomics can identify key mechanisms regulating radioresistance, such as DNA repair, hypoxia, and metabolic reprogramming.
• Proteomic approaches have identified potential biomarkers predictive of radiosensitivity and radioresistance across different tumor types.
• Technological advancements are enhancing the comprehensive analysis of radiobiology.

Conclusions:

• Proteomics is a key approach in precision medicine for understanding tumor heterogeneity and treatment response.
• Incorporating proteomics into radiotherapy workflows can enhance treatment efficacy and minimize toxicity.
• Further advancements in proteomics will aid in overcoming radiation resistance and guiding personalized cancer treatment strategies.